Whilst GLP-1 receptor agonists are not prescribed solely for hypertension management, certain patient populations may derive particular benefit from their blood pressure-lowering effects alongside their primary metabolic indications
These medications require a prescription and professional supervision, as potential side effects might include nausea, diarrhea, constipation, or abdominal discomfort
Ajanta Pharma has now brokered similar regional in-licensing deals for semaglutide, accelerating distribution across over 20 countries in the Middle East and Africa
Tirzepatide (Mounjaro/Zepbound), the dual GLP-1/GIP agonist, has 2-3 years of real-world experience with roughly 5-7 million patients and shows a similar pattern of sustained effectiveness
It teaches your body basically what to do with insulin
Why the Day Before Matters The day before your injection is when many people can eat a little more normally